SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-005315
Filing Date
2018-01-08
Accepted
2018-01-08 10:01:03
Documents
4
Period of Report
2018-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d480443d8k.htm 8-K 21352
2 EX-10.1 d480443dex101.htm EX-10.1 96369
3 EX-99.1 d480443dex991.htm EX-99.1 11551
4 GRAPHIC g480443g11s35.jpg GRAPHIC 5077
  Complete submission text file 0001193125-18-005315.txt   137598
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 18515180
SIC: 2834 Pharmaceutical Preparations